Category Archives: Research

More Biotech Hub Rankings

GEN (Genetic Engineering and Biotechnology News) has released their own, more comprehensive biotech hub rankings.  As expected, Boston-Cambridge and the Bay Area are at the top, with San Francisco edging out Boston in most criteria.  The GEN rankings include not only … Continue reading

Posted in Innovation, Research | Tagged , , , | Leave a comment

Venture Funding of Biotech is VERY Concentrated… and Very Limited

Fierce Biotech has released their latest analysis of venture capital funding of biotech in the U.S. last year, broken down by metropolitan area: Source: San Francisco is back out in front, edging out Boston-Cambridge.  After San Diego and Washington, funding … Continue reading

Posted in Innovation, Research | Tagged , , , , , , | Leave a comment

Product Cycles in the Pharma Industry and How to “Shorten” Them – Part 1

A few weeks ago I commented on what may be the fundamental limit on a stable Pharmaceutical industry — products have to be on the market for at least as long as it takes to replace them.  Cash flow significant … Continue reading

Posted in Fixing Big Pharma Research, Management, Research | Leave a comment

Boston-Cambridge is THE Life Sciences Hub

Luke Timmerman from Xconomy has published an analysis of where the major Life Sciences companies are located. Using the criteria of having $100 million in cash and short term assets as the definition of a major firm, his analysis highlights … Continue reading

Posted in Innovation, Research | Tagged , , , , , , , | 1 Comment

Fixing Big Pharma Research: The costs of delays need to be properly valued

For the Pharmaceutical industry, the foregone revenue created by delays in bringing a drug to market can be surprisingly high — from $50,000 to $2,000,000 per day, depending on the phase of the pipeline. Such costs are often under appreciated. … Continue reading

Posted in Management, Research | Tagged , , , | Leave a comment

Fixing Big Pharma Research: Introduction

Lots of articles and blog posts get written about the research productivity crisis in the pharmaceutical industry.  A lot of Wall Street types argue that Pharma companies simply must spend less on R&D (Recently, yet another analyst called for a … Continue reading

Posted in Research | Tagged , , , , , , | 1 Comment

How to fix big Pharma R&D in three easy steps?

Bruce Booth has three thought-provoking suggestions about what he’d do if he was in charge of Pharma R&D at a large company: “Invert the periphery and the core”, “Get the rest of the company out of the way of research”, … Continue reading

Posted in Research | Leave a comment